Our study covers a broad group of patients and provides strong support that GLP-1 analogues are not associated with an increased risk of thyroid cancer. The researchers analysed national register data from Denmark, Norway, and Sweden of about 145,000 patients treated with GLP-1 analogues, mainly liraglutide or semaglutide, and 290,000 patients treated with another diabetes drug (DPP4 inhibitors)
Gutierrez AD, Gao Z, Hamidi V, Zhu L, Saint Andre KB, Riggs K, et al
Gutterman JU, Mavligit G, McBride C, Frei E 3rd, Freireich EJ, Hersh EM
Synergistic Effect: CJC-1295 amplifies natural GH pulses while Ipamorelin triggers additional release Sustained Release: CJC-1295's extended half-life maintains baseline GH levels Minimal Side Effects: Avoids cortisol and prolactin increases Natural Pattern: Mimics physiological GH secretion Use our free peptide dosage calculator to determine the right dose for your body weight and goals